心力衰竭病理生理学中的非编码RNA与保存的射出分数
Elisabeth A Jalink1,2, Amber W Schonk1,2, Reinier A Boon1,2,3,4
1Department of Physiology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Frontiers in cardiovascular medicine
|January 23, 2024
概括
非编码RNAs (ncRNAs),如微RNAs,长非编码RNAs和圆形RNAs在心力衰竭中至关重要. 了解它们的作用为这种具有挑战性的心血管疾病提供了新的诊断和治疗策略.
科学领域:
- 心血管医学 心血管医学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭代表了心血管医学中的重大未满足需求.
- 目前对HFpEF的治疗选择有限,因为对其潜在的分子机制的理解不完全.
- 非编码RNAs (ncRNAs),包括microRNAs (miRNAs),长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs),与心血管疾病有关,但它们在HFpEF中的作用基本上是未知的.
研究的目的:
- 讨论miRNAs,lncRNAs和circRNAs在HFpEF病理生理学的参与.
- 探索ncRNAs对HFpEF特征的分子机制,例如微血管功能障碍,炎症,腹功能障碍和心脏纤维化.
- 评估ncRNAs作为HFpEF生物标志物和治疗点的潜力.
主要方法:
- 审查和讨论与HFpEF中ncRNA相关的现有临床证据.
- 使用模拟HFpEF并发症的相关体内和体外模型对分子机制进行剖析.
- 对调查特定miRNAs,lncRNAs和circRNAs在HFpEF病原发生中的作用的研究进行分析.
主要成果:
- ncRNAs在HFpEF的关键病理生理过程中发挥着重要作用,包括微血管功能障碍,炎症,腹功能障碍和心脏纤维化.
- 已经确定了特定的ncRNAs,这些ncRNAs在HFpEF中失调,并导致疾病进展.
- 试验室和体内模型证明了ncRNAs对与HFpEF相关的心脏细胞和组织的功能影响.
结论:
- ncRNAs是HFpEF分子基础的组成部分.
- 特定ncRNAs的失调有助于HFpEF的发展和进展.
- ncRNAs作为HFpEF诊断和预后的潜在生物标志物以及未来治疗的新治疗点具有前景.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
432
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
432
01:22Heart Failure Drugs: Diuretics
384
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
384
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:20Types of RNA
5.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.8K
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341